Cargando…
Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
Alzheimer’s disease (AD) is the most common chronic neurodegenerative disease worldwide. It causes cognitive dysfunction, such as aphasia and agnosia, and mental symptoms, such as behavioral abnormalities; all of which place a significant psychological and economic burden on the patients’ families....
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438465/ https://www.ncbi.nlm.nih.gov/pubmed/37600514 http://dx.doi.org/10.3389/fnagi.2023.1206572 |